Invega sustenna and Antisocial behavior - a phase IV clinical study of FDA data

Summary:

Antisocial behavior is reported as a side effect among people who take Invega sustenna (paliperidone palmitate), especially for people who are male, 20-29 old, have been taking the drug for 1 - 6 months also take Invega, and have Arthritis.

The phase IV clinical study analyzes which people have Antisocial behavior when taking Invega sustenna. It is created by eHealthMe based on reports of 23,130 people who have side effects when taking Invega sustenna from the FDA, and is updated regularly.

What is Invega sustenna?

Invega sustenna has active ingredients of paliperidone palmitate. It is often used in schizophrenia. eHealthMe is studying from 23,232 Invega sustenna users. Check the latest studies of Invega sustenna.

What is Antisocial behavior?

Antisocial behavior is found to be associated with 159 drugs and 335 conditions by eHealthMe. Check the latest studies of Antisocial behavior.

On Jul, 13, 2026

23,130 people reported to have side effects when taking Invega sustenna.
Among them, 17 people (0.07%) have Antisocial behavior.

Could Invega sustenna cause Antisocial behavior?

Among these 17 people:

How long have people been on Invega sustenna when they have Antisocial behavior? *

What is the gender of people who have Antisocial behavior when taking Invega sustenna? *

female: 20 %
male: 80 %

What is the age of people who have Antisocial behavior when taking Invega sustenna? *

What are other drugs people take besides Invega sustenna? *

What are other side effects people have besides Antisocial behavior? *

Aggression: 4 people, 23.53%
Thinking Abnormal: 4 people, 23.53%
Weight Increased: 3 people, 17.65%
Feeling Abnormal: 3 people, 17.65%
Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 3 people, 17.65%
Abnormal Behavior: 3 people, 17.65%
Sluggishness (lacking alertness): 2 people, 11.76%
Insomnia (sleeplessness): 2 people, 11.76%
Fatigue (feeling of tiredness): 2 people, 11.76%
Apathy: 2 people, 11.76%

What are the existing conditions these people have? *

Schizophrenia, Paranoid Type (delusions and auditory hallucinations but relatively normal intellectual functioning and expression of affect): 1 person, 5.88%
Pain: 1 person, 5.88%
High Blood Pressure: 1 person, 5.88%
Enlarged Prostate: 1 person, 5.88%
Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 1 person, 5.88%
Bipolar Disorder (mood disorder): 1 person, 5.88%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Invega sustenna and have Antisocial behavior?

- Check whether Antisocial behavior is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Invega sustenna:

Invega sustenna (23,232 reports)

Browse all side effects of Invega sustenna:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Antisocial behavior:

Antisocial behavior (159 drugs)

Browse all the conditions that are associated with Antisocial behavior:

Antisocial behavior (335 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on paliperidone palmitate (the active ingredients of Invega sustenna) and Invega sustenna (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.